Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-25 11:45 am Purchase | 2025-03-13 | 13D | The Lovesac Company LOVE | Anson Funds Management LP | 932,261 6.000% | 117,898 (+14.48%) | Filing History |
| 2025-02-14 7:10 pm Purchase | 2024-12-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Anson Funds Management LP | 151,501 4.900% | 149,900 (+9364.25%) | Filing History |
| 2025-02-14 6:36 pm Purchase | 2024-12-31 | 13G | 180 Life Sciences Corp. ATNF | Anson Funds Management LP | 225,271 7.100% | 225,271 (New Position) | Filing History |
| 2025-02-14 6:32 pm Unchanged | 2024-12-31 | 13G | Cyngn Inc. CYN | Anson Funds Management LP | 14,802 9.900% | 0 (Unchanged) | Filing History |
| 2025-02-14 6:30 pm Purchase | 2024-12-31 | 13G | Oncolytics Biotech Inc. ONCY | Anson Funds Management LP | 8,185,743 9.600% | 8,185,743 (New Position) | Filing History |
| 2025-02-14 6:29 pm Purchase | 2024-12-31 | 13G | LogicMark, Inc. LGMK | Anson Funds Management LP | 128,385 0.300% | 101,458 (+376.78%) | Filing History |
| 2025-02-14 6:26 pm Purchase | 2024-12-31 | 13G | SRM Entertainment, Inc. SRM | Anson Funds Management LP | 1,395,235 9.600% | 1,395,235 (New Position) | Filing History |
| 2025-02-14 6:22 pm Purchase | 2024-01-31 | 13G | Digital Ally, Inc. DGLY | Anson Funds Management LP | 576,541 9.900% | 576,541 (New Position) | Filing History |
| 2025-02-14 5:24 pm Purchase | 2024-12-31 | 13G | Universe Pharmaceuticals INC UPC | Anson Funds Management LP | 19,558 9.900% | 19,558 (New Position) | Filing History |
| 2025-02-14 5:22 pm Purchase | 2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | Anson Funds Management LP | 411,681 2.100% | 346,111 (+527.85%) | Filing History |
| 2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Anson Funds Management LP | 113,479 9.900% | 113,479 (New Position) | Filing History |
| 2025-02-14 2:46 pm Purchase | 2024-12-31 | 13G | 22nd Century Group, Inc. XXII | Anson Funds Management LP | 2,432,220 4.900% | 2,408,957 (+10355.49%) | Filing History |
| 2025-02-14 2:11 pm Sale | 2024-12-31 | 13G | Meihua International Medical Technologies Co., Ltd. MHUA | Anson Funds Management LP | 1,205,255 4.800% | -1,062,046 (-46.84%) | Filing History |
| 2025-02-14 11:48 am Purchase | 2024-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Anson Funds Management LP | 367,950 1.400% | 361,564 (+5662.18%) | Filing History |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | Cemtrex, Inc. CETX | Anson Funds Management LP | 90,554 4.900% | 35,259 (+63.76%) | Filing History |
| 2025-02-14 07:08 am Purchase | 2024-12-31 | 13G | Cyngn Inc. CYN | Anson Funds Management LP | 14,802 9.900% | 14,802 (New Position) | Filing History |
| 2024-11-14 6:08 pm Purchase | 2024-09-30 | 13G | Meihua International Medical Technologies Co., Ltd. MHUA | Anson Funds Management LP | 2,267,301 9.500% | 2,267,301 (New Position) | Filing History |
| 2024-11-14 6:01 pm Purchase | 2024-09-30 | 13G | ZyVersa Therapeutics, Inc. ZVSA | Anson Funds Management LP | 54,054 4.900% | 54,054 (New Position) | Filing History |
| 2024-11-14 5:58 pm Purchase | 2024-09-30 | 13G | LogicMark, Inc. LGMK | Anson Funds Management LP | 26,927 9.900% | 26,927 (New Position) | Filing History |
| 2024-11-14 5:56 pm Purchase | 2024-09-30 | 13G | 22nd Century Group, Inc. XXII | Anson Funds Management LP | 23,263 9.900% | 23,263 (New Position) | Filing History |